{"id":"ornidazole-and-sodium-chloride-injection","safety":{"commonSideEffects":[{"rate":null,"effect":"Metallic taste"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Peripheral neuropathy (with prolonged use)"},{"rate":null,"effect":"Allergic reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Ornidazole penetrates microbial cells and undergoes reduction of its 5-nitro group by anaerobic metabolism, producing reactive intermediates that damage DNA and inhibit nucleic acid synthesis. This mechanism is effective against anaerobic bacteria and certain protozoa. The sodium chloride component is a physiological saline carrier for intravenous administration.","oneSentence":"Ornidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:59:04.497Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Anaerobic bacterial infections"},{"name":"Protozoal infections (e.g., trichomoniasis, amebiasis)"},{"name":"Surgical prophylaxis for anaerobic infection"}]},"trialDetails":[{"nctId":"NCT06828874","phase":"PHASE4","title":"A Study of Levornidazole Disodium Phosphate for Injection vs. Ornidazole in Treatment of Postoperative Intra-Abdominal Infections Caused by Anaerobic Bacteria","status":"COMPLETED","sponsor":"Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd","startDate":"2023-05-10","conditions":"Intraabdominal Infections","enrollment":696}],"_emaApprovals":[],"_faersSignals":[{"count":1,"reaction":"ABDOMINAL DISCOMFORT"},{"count":1,"reaction":"ANAEMIA"},{"count":1,"reaction":"ATRIAL FIBRILLATION"},{"count":1,"reaction":"BLOOD ALBUMIN DECREASED"},{"count":1,"reaction":"BODY TEMPERATURE INCREASED"},{"count":1,"reaction":"CYANOSIS"},{"count":1,"reaction":"ELECTROCARDIOGRAM ST SEGMENT ABNORMAL"},{"count":1,"reaction":"EXTRASYSTOLES"},{"count":1,"reaction":"MUSCLE SPASMS"},{"count":1,"reaction":"TREMOR"}],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Ornidazole and Sodium Chloride Injection","genericName":"Ornidazole and Sodium Chloride Injection","companyName":"Yangtze River Pharmaceutical Group Jiangsu Zilong Pharmaceutical Co. Ltd","companyId":"yangtze-river-pharmaceutical-group-jiangsu-zilong-pharmaceutical-co-ltd","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Ornidazole is a nitroimidazole antibiotic that disrupts bacterial and parasitic DNA by generating reactive oxygen species after reduction of its nitro group. Used for Anaerobic bacterial infections, Protozoal infections (e.g., trichomoniasis, amebiasis), Surgical prophylaxis for anaerobic infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}